CN111093399A - 与包含鱼油和/或ω-3脂肪酸的乳剂有关的方法和组合物 - Google Patents

与包含鱼油和/或ω-3脂肪酸的乳剂有关的方法和组合物 Download PDF

Info

Publication number
CN111093399A
CN111093399A CN201880058296.9A CN201880058296A CN111093399A CN 111093399 A CN111093399 A CN 111093399A CN 201880058296 A CN201880058296 A CN 201880058296A CN 111093399 A CN111093399 A CN 111093399A
Authority
CN
China
Prior art keywords
emulsion
emulsion composition
fatty acids
omega
fish oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201880058296.9A
Other languages
English (en)
Chinese (zh)
Inventor
马克·布德
凯瑟琳·古拉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Childrens Hospital
Original Assignee
Boston Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Childrens Hospital filed Critical Boston Childrens Hospital
Priority to CN202311633119.8A priority Critical patent/CN117918525A/zh
Priority to CN202311628291.4A priority patent/CN118000419A/zh
Publication of CN111093399A publication Critical patent/CN111093399A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Pediatric Medicine (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN201880058296.9A 2017-08-10 2018-08-10 与包含鱼油和/或ω-3脂肪酸的乳剂有关的方法和组合物 Pending CN111093399A (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202311633119.8A CN117918525A (zh) 2017-08-10 2018-08-10 与包含鱼油和/或ω-3脂肪酸的乳剂有关的方法和组合物
CN202311628291.4A CN118000419A (zh) 2017-08-10 2018-08-10 与包含鱼油和/或ω-3脂肪酸的乳剂有关的方法和组合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762543437P 2017-08-10 2017-08-10
US62/543,437 2017-08-10
PCT/US2018/046206 WO2019032959A1 (en) 2017-08-10 2018-08-10 METHODS AND COMPOSITIONS RELATING TO EMULSIONS COMPRISING FISH OIL AND / OR OMEGA-3 FATTY ACIDS

Related Child Applications (2)

Application Number Title Priority Date Filing Date
CN202311628291.4A Division CN118000419A (zh) 2017-08-10 2018-08-10 与包含鱼油和/或ω-3脂肪酸的乳剂有关的方法和组合物
CN202311633119.8A Division CN117918525A (zh) 2017-08-10 2018-08-10 与包含鱼油和/或ω-3脂肪酸的乳剂有关的方法和组合物

Publications (1)

Publication Number Publication Date
CN111093399A true CN111093399A (zh) 2020-05-01

Family

ID=65271269

Family Applications (3)

Application Number Title Priority Date Filing Date
CN202311633119.8A Pending CN117918525A (zh) 2017-08-10 2018-08-10 与包含鱼油和/或ω-3脂肪酸的乳剂有关的方法和组合物
CN202311628291.4A Pending CN118000419A (zh) 2017-08-10 2018-08-10 与包含鱼油和/或ω-3脂肪酸的乳剂有关的方法和组合物
CN201880058296.9A Pending CN111093399A (zh) 2017-08-10 2018-08-10 与包含鱼油和/或ω-3脂肪酸的乳剂有关的方法和组合物

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CN202311633119.8A Pending CN117918525A (zh) 2017-08-10 2018-08-10 与包含鱼油和/或ω-3脂肪酸的乳剂有关的方法和组合物
CN202311628291.4A Pending CN118000419A (zh) 2017-08-10 2018-08-10 与包含鱼油和/或ω-3脂肪酸的乳剂有关的方法和组合物

Country Status (16)

Country Link
US (2) US11324697B2 (enExample)
EP (2) EP4450090A3 (enExample)
JP (1) JP7370317B2 (enExample)
KR (2) KR102677006B1 (enExample)
CN (3) CN117918525A (enExample)
AU (1) AU2018313260B2 (enExample)
CA (1) CA3070481A1 (enExample)
DK (1) DK3664628T3 (enExample)
ES (1) ES3012510T3 (enExample)
FI (1) FI3664628T3 (enExample)
HR (1) HRP20250125T1 (enExample)
PH (1) PH12020500267A1 (enExample)
PL (1) PL3664628T3 (enExample)
PT (1) PT3664628T (enExample)
SG (2) SG11202000592WA (enExample)
WO (1) WO2019032959A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021243526A1 (zh) * 2020-06-01 2021-12-09 苏州大学附属儿童医院 新生儿肠外营养相关性肝病特异性标志物lncRNA的应用

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021177974A1 (en) * 2020-03-06 2021-09-10 Optimega Llc Fatty acid compositions for enteral use
EP4181876A1 (en) * 2020-07-14 2023-05-24 Nutrition Lipid Developments Isotonic lipid emulsion
KR20230010404A (ko) 2021-07-12 2023-01-19 에이치케이이노엔 주식회사 오메가 지방산을 포함하는 약학 조성물 및 이를 포함하는 수액제제
CN116754711B (zh) * 2023-08-17 2023-11-07 蓝星安迪苏南京有限公司 饲料用乳化剂的乳化能力评估方法

Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003002A1 (en) * 1984-01-16 1985-07-18 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides
WO1990008544A1 (de) * 1989-02-02 1990-08-09 B. Braun Melsungen Aktiengesellschaft Omega-3-fettsäurehaltige fettemulsion zur intraperitonealen applikation, ihre herstellung und anwendung
US5574065A (en) * 1994-04-21 1996-11-12 Clintec Nutrition Co. Method and composition for normalizing injury response
CN1202823A (zh) * 1995-11-28 1998-12-23 B·布朗·梅尔松根有限公司 最优化水解的脂质乳剂及其用途
US5874470A (en) * 1987-10-09 1999-02-23 B. Braun Melsungen Ag Isotonic fat emulsion containing omega-3-fatty acids and use thereof
US6020020A (en) * 1995-11-24 2000-02-01 Loders-Croklaan B.V. Composition based on fish oil
US20040247693A1 (en) * 2001-07-25 2004-12-09 Yvon Carpentier Modifying the fatty acid composition of cell membranes of organs and tissues
US20060004099A1 (en) * 2004-07-02 2006-01-05 Baylor Research Institute Glycogen or polysaccharide storage disease treatment method
US20060127491A1 (en) * 2003-11-12 2006-06-15 Children's Medical Center Corporation Treatment and prevention of liver disease associated with parenteral nutrition (PN)
CN1965806A (zh) * 2006-11-09 2007-05-23 华瑞制药有限公司 一种含大豆油、中链甘油三酯、橄榄油和鱼油的脂肪乳注射液及其制造方法
CN101037641A (zh) * 2001-07-02 2007-09-19 三得利株式会社 含有含多不饱和脂肪酸的甘油三酯的油或脂肪的生产方法
US20070281993A1 (en) * 2004-03-04 2007-12-06 Geila Rozen Structured Triglycerides And Emulsions Comprising Same
US20100233280A1 (en) * 2009-03-11 2010-09-16 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
CN101981002A (zh) * 2008-01-22 2011-02-23 斯蒂潘公司 磺化的交内酯和其它脂肪酸的衍生物、它们的制备方法以及使用它们的组合物和方法
US20120040934A1 (en) * 2009-03-11 2012-02-16 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
WO2012172411A1 (en) * 2011-06-15 2012-12-20 Stable Solutions Llc Therapeutic application of parenteral krill oil
US20130137770A1 (en) * 2010-04-23 2013-05-30 Michael Lewis Intravenous omega-3 fatty acid compositions & method of use
US20140120171A1 (en) * 2011-06-15 2014-05-01 Stable Solutions Llc Therapeutic application of parenteral krill oil
US20150011515A1 (en) * 2012-02-29 2015-01-08 B. Braun Melsungen Ag Hormone Containing Emulsion
WO2016040570A2 (en) * 2014-09-12 2016-03-17 Children's Medical Center Corporation Dietary emulsion formulations and methods for using the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2738253A1 (de) 1977-08-25 1979-03-01 Dabisch Tipp Ex Tech Koerper mit reversibel temperaturabhaengiger transparenz
DE2749265A1 (de) 1977-11-03 1979-05-10 Linde Ag Verfahren zur biologischen reinigung von abwasser
US4703062A (en) * 1984-01-16 1987-10-27 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides
US4752618A (en) 1984-07-12 1988-06-21 New England Deaconess Hospital Method of minimizing efects of infection through diet
DE3722540A1 (de) 1987-07-08 1989-01-19 Fresenius Ag Fettemulsion, verfahren zu ihrer herstellung und ihre verwendung
SE9101642D0 (sv) 1991-05-30 1991-05-30 Kabi Pharmacia Ab Phospholipids
US5436269A (en) 1991-11-14 1995-07-25 Sagami Chemical Research Center Method for treating hepatitis
US5728385A (en) 1993-08-12 1998-03-17 Classen Immunotherapies, Inc. Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae
US20030068385A1 (en) 2001-03-23 2003-04-10 Moyer Mary Pat Accelerated action fatty acid (AAFA) promotes health of normal tissues and minimizes the toxic side effects of chemotherapy
FI114894B (fi) 2002-05-02 2005-01-31 Omecol Finland Oy Elintarvikekoostumus
DE10254584A1 (de) * 2002-11-22 2004-06-09 HORST HEIRLER PROJEKTE für Ernährung, Medizin, Ökologie Verwendung von mittelkettigen Triglyceriden (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätetischen Lebensmittel für Diabetiker
US8410181B2 (en) 2006-09-19 2013-04-02 The Trustees Of Columbia University In The City Of New York Omega-3 diglyceride emulsions
US20120277316A1 (en) 2010-01-19 2012-11-01 University of Tennesse Research Foundation a university Methods and compositions for treating and preventing parenteral nutrition associated liver disease
WO2013063067A1 (en) 2011-10-24 2013-05-02 Stable Solutions Llc Enriched injectable emulsion containing selected fatty acid triglycerides
AU2016240201A1 (en) 2015-03-31 2017-05-25 Fresenius Kabi Deutschland Gmbh Emulsions for parenteral administration

Patent Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003002A1 (en) * 1984-01-16 1985-07-18 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides
US5874470A (en) * 1987-10-09 1999-02-23 B. Braun Melsungen Ag Isotonic fat emulsion containing omega-3-fatty acids and use thereof
WO1990008544A1 (de) * 1989-02-02 1990-08-09 B. Braun Melsungen Aktiengesellschaft Omega-3-fettsäurehaltige fettemulsion zur intraperitonealen applikation, ihre herstellung und anwendung
US5574065A (en) * 1994-04-21 1996-11-12 Clintec Nutrition Co. Method and composition for normalizing injury response
US6020020A (en) * 1995-11-24 2000-02-01 Loders-Croklaan B.V. Composition based on fish oil
CN1202823A (zh) * 1995-11-28 1998-12-23 B·布朗·梅尔松根有限公司 最优化水解的脂质乳剂及其用途
US6008248A (en) * 1995-11-28 1999-12-28 B. Braun Melsungen Ag Hydrolysis-optimized lipid emulsions and use thereof
CN101037641A (zh) * 2001-07-02 2007-09-19 三得利株式会社 含有含多不饱和脂肪酸的甘油三酯的油或脂肪的生产方法
US20040247693A1 (en) * 2001-07-25 2004-12-09 Yvon Carpentier Modifying the fatty acid composition of cell membranes of organs and tissues
US20060127491A1 (en) * 2003-11-12 2006-06-15 Children's Medical Center Corporation Treatment and prevention of liver disease associated with parenteral nutrition (PN)
US20070281993A1 (en) * 2004-03-04 2007-12-06 Geila Rozen Structured Triglycerides And Emulsions Comprising Same
US20060004099A1 (en) * 2004-07-02 2006-01-05 Baylor Research Institute Glycogen or polysaccharide storage disease treatment method
CN1965806A (zh) * 2006-11-09 2007-05-23 华瑞制药有限公司 一种含大豆油、中链甘油三酯、橄榄油和鱼油的脂肪乳注射液及其制造方法
CN101981002A (zh) * 2008-01-22 2011-02-23 斯蒂潘公司 磺化的交内酯和其它脂肪酸的衍生物、它们的制备方法以及使用它们的组合物和方法
US20100233280A1 (en) * 2009-03-11 2010-09-16 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US20120040934A1 (en) * 2009-03-11 2012-02-16 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US20130137770A1 (en) * 2010-04-23 2013-05-30 Michael Lewis Intravenous omega-3 fatty acid compositions & method of use
WO2012172411A1 (en) * 2011-06-15 2012-12-20 Stable Solutions Llc Therapeutic application of parenteral krill oil
US20140120171A1 (en) * 2011-06-15 2014-05-01 Stable Solutions Llc Therapeutic application of parenteral krill oil
US20150011515A1 (en) * 2012-02-29 2015-01-08 B. Braun Melsungen Ag Hormone Containing Emulsion
WO2016040570A2 (en) * 2014-09-12 2016-03-17 Children's Medical Center Corporation Dietary emulsion formulations and methods for using the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
（美）惠（HUI, Y.H.）, 上海：上海科学技术出版社 *
赵书广: "《中国养猪大成》", 31 March 2001, 北京：中国农业出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021243526A1 (zh) * 2020-06-01 2021-12-09 苏州大学附属儿童医院 新生儿肠外营养相关性肝病特异性标志物lncRNA的应用

Also Published As

Publication number Publication date
KR20200038472A (ko) 2020-04-13
SG11202000592WA (en) 2020-02-27
US11324697B2 (en) 2022-05-10
CN117918525A (zh) 2024-04-26
EP4450090A3 (en) 2025-01-29
ES3012510T3 (en) 2025-04-09
EP4450090A2 (en) 2024-10-23
US20220226238A1 (en) 2022-07-21
FI3664628T3 (fi) 2025-02-04
RU2020109759A3 (enExample) 2021-11-15
PL3664628T3 (pl) 2025-04-07
WO2019032959A1 (en) 2019-02-14
KR102677006B1 (ko) 2024-06-25
DK3664628T3 (da) 2025-01-13
KR20240101693A (ko) 2024-07-02
RU2020109759A (ru) 2021-09-10
PH12020500267A1 (en) 2020-09-21
US20200345638A1 (en) 2020-11-05
HRP20250125T1 (hr) 2025-03-28
PT3664628T (pt) 2024-12-31
EP3664628A4 (en) 2021-04-14
JP2020530464A (ja) 2020-10-22
BR112020002638A2 (pt) 2020-08-18
AU2018313260B2 (en) 2024-06-20
JP7370317B2 (ja) 2023-10-27
EP3664628B1 (en) 2024-12-11
CN118000419A (zh) 2024-05-10
CA3070481A1 (en) 2019-02-14
SG10202108769WA (en) 2021-09-29
AU2018313260A1 (en) 2020-01-16
EP3664628A1 (en) 2020-06-17

Similar Documents

Publication Publication Date Title
US20220226238A1 (en) Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids
AU2010201897B2 (en) Dietary supplement composition for blood lipid health
CN103813790A (zh) Gip上升抑制剂
RU2783166C9 (ru) Способы и композиции, относящиеся к эмульсиям, содержащим рыбий жир и/или омега-3 жирные кислоты
RU2783166C2 (ru) Способы и композиции, относящиеся к эмульсиям, содержащим рыбий жир и/или омега-3 жирные кислоты
HK40022806A (en) Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids
JP2010229099A (ja) 脂質異常症の改善または治療薬
WO2020259493A1 (en) Compositions and methods for the prevention or treatment, or dietary management of nafld
HK40023767B (en) Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids
HK40023767A (en) Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids
BR112020002638B1 (pt) Métodos e composições relativas a emulsões compreendendo óleo de peixe e/ou ácidos graxos ômega-3
WO2023107527A1 (en) Methods and compositions relating to treatment and prevention of fatty acid deficiencies
JP7422160B2 (ja) アクアポリン３の発現調節を介した腸機能改善用組成物及びその使用
JPWO2013002404A1 (ja) 恐怖記憶の軽減方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40022806

Country of ref document: HK